Alastair Kilgour
Fondateur chez Parkwalk Advisors Ltd. (Venture Capital)
Fortune : 11 440 $ au 31/05/2024
Postes actifs de Alastair Kilgour
Sociétés | Poste | Début | Fin |
---|---|---|---|
Parkwalk Advisors Ltd. (Venture Capital)
Parkwalk Advisors Ltd. (Venture Capital) Investment ManagersFinance Parkwalk Advisors Ltd. (Parkwalk Advisors) is a venture capital firm founded in 2009 by Moray Wright and Alastair Hugh Lowell Kilgour. The firm is headquartered in London, United Kingdom. | Directeur en chef des Investissements | 05/06/2009 | - |
Fondateur | 05/06/2009 | - | |
Private Equity Investor | 05/06/2009 | - | |
Congenica Ltd.
Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Directeur en chef des Investissements | - | - | |
Albert Innovations Ltd. | Directeur/Membre du Conseil | - | - |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Victoria Innovations Ltd. | Directeur/Membre du Conseil | 02/12/2016 | - |
Historique de carrière de Alastair Kilgour
Anciens postes connus de Alastair Kilgour
Sociétés | Poste | Début | Fin |
---|---|---|---|
MIRRIAD ADVERTISING PLC | Directeur/Membre du Conseil | 19/12/2017 | 01/06/2023 |
Independent Dir/Board Member | 19/12/2017 | - | |
Predictimmune Ltd.
Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - | 19/07/2019 |
ARK Securities Ltd. | Corporate Officer/Principal | - | - |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 25/05/2018 | - |
░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Statistiques
Internationale
Royaume-Uni | 12 |
Opérationnelle
Director/Board Member | 8 |
Chief Investment Officer | 2 |
Founder | 2 |
Sectorielle
Health Technology | 5 |
Finance | 3 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MIRRIAD ADVERTISING PLC | Commercial Services |
Entreprise privées | 10 |
---|---|
Parkwalk Advisors Ltd. (Venture Capital)
Parkwalk Advisors Ltd. (Venture Capital) Investment ManagersFinance Parkwalk Advisors Ltd. (Parkwalk Advisors) is a venture capital firm founded in 2009 by Moray Wright and Alastair Hugh Lowell Kilgour. The firm is headquartered in London, United Kingdom. | Finance |
First Light Fusion Ltd.
First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | Commercial Services |
Parkwalk Advisors Ltd.
Parkwalk Advisors Ltd. Investment ManagersFinance Parkwalk Advisors Ltd. provides investment advisory services. The company was founded by Alastair Kilgour in 2009 and is headquartered in London, the United Kingdom. | Finance |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Predictimmune Ltd.
Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Congenica Ltd.
Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Health Technology |
Albert Innovations Ltd. | |
ARK Securities Ltd. | |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Victoria Innovations Ltd. |
- Bourse
- Insiders
- Alastair Kilgour
- Expérience